Additionally, the structure of CD28 can be modified for superior persistence and reduced exhaustion, as shown in a B-ALL mouse model in which both CD28 YMNM and PRRP motifs were mutated while the PYAP motif remained intact [65]. This evidence concerns the gene CD28 and precursor B-cell acute lymphoblastic leukemia.